SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.48+0.7%Nov 14 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bluegreen who wrote (16857)5/12/2004 10:40:18 AM
From: aknahow  Read Replies (4) of 17367
 
A mining company tells you where they are going to drill. Projected depth. When drilling will begin. The assay results when submitted to the company.

A biotech company does not need to tell you what they are doing, nor when they will start doing what they have not told you, nor when they are thru doing it, nor what the results were. What starts out as a core project gets reversed into a probe.

Then when and if a product is approved, a biotech does not need to tell you how much actual sales are.

But investors keep buying the stock.

Should one blame a company like Xoma, or the ones that keep buying it even when the information flow does not permit making an informed decision?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News